Search results

Filters

  • Journals
  • Authors
  • Keywords
  • Date
  • Type

Search results

Number of results: 2
items per page: 25 50 75
Sort by:
Download PDF Download RIS Download Bibtex

Abstract

Erythritol (ERT) and L-ascorbyl-2-phosphate (APS) are bacteriostatic, but their effects on staphylococcal skin infections remain unknown. We aimed to determine whether ERT combined with APS inhibits the growth of staphylococci that are commonly isolated from pyoderma skin lesions in dogs. We investigated the individual and combined effects of ERT and APS on the growth of Staphylococcus pseudintermedius, S. schleiferi, and S. aureus using turbidity assays in vitro. Skin lesions from 10 dogs with superficial pyoderma were topically treated with 5% ERT and 0.1% APS for 28 days, and swabbed skin samples were then analyzed using 16S rRNA amplicon sequencing and quantitative real-time PCR (qPCR). Results showed that ERT inhibited S. pseudintermedius growth regardless of harboring the mecA gene, and APS increased the inhibitory effects of ERT against S. pseudintermedius, S. schleiferi, and S. aureus in vitro. Moreover, combined ERT and APS decreased the prevalence of staphylococci on canine skin lesions at the genus level. The combination slightly increased the α-diversity but did not affect the β-diversity of the microbiota. The qPCR results revealed that the combination significantly decreased S. pseudintermedius and S. schleiferi in skin lesions. Topical administration of EPS combined with APS can prevent staphylococcal colonization on the surface of mammalian skin. The results of this study may provide an alternative to systemic antibiotics for treating superficial pyoderma on mammalian skin surfaces.
Go to article

Bibliography

1. Akiyama H, Oono T, Huh WK, Yamasaki O, Katsuyama M, Shigeyuki O, Ichikawa H, Iwatsuki K (2002) Actions of farnesol and xyli-tol against Staphylococcus aureus. Chemotherapy 48: 122-128.
2. Bradley CW, Morris DO, Rankin SC, Cain CL, Misic AM, Houser T, Mauldin EA, Grice EA (2016) Longitudinal evaluation of the skin microbiome and association with microenvironment and treatment in canine atopic dermatitis. J Invest Dermatol 136: 1182-1190.
3. Dean I, Jackson F, Greenough RJ (1996) Chronic (1-year) oral toxicity study of erythritol in dogs. Regul Toxicol Pharmacol 24: S254-S260.
4. Drago L, Del Fabbro M, Bortolin M, Vassena C, De Vecchi E, Taschieri S (2014) Biofilm removal and antimicrobial activity of two dif-ferent air-polishing powders: an in vitro study. J Periodontol 85: e363-e369.DuHadway MR, Sharp CR, Meyers KE, Koenigshof AM. (2015) Retrospective evaluation of xylitol ingestion in dogs: 192 cases (2007-2012). J Vet Emerg Crit Care (San Antonio). 25: 646-654.
5. Fujii T, Inoue S, Kawai Y, Tochio T, Takahashi K (2022) Suppression of axillary odor and control of axillary bacterial flora by erythritol. J Cosmet Dermatol 21: 1224-1233.
6. González-Domínguez MS, Carvajal HD, Calle-Echeverri DA, Chinchilla-Cárdenas D. (2020) Molecular detection and characterization of the mecA and nuc genes From Staphylococcus species (S. aureus, S. pseudintermedius, and S. schleiferi) isolated from dogs suffering superficial pyoderma and their antimicrobial resistance profiles. Front Vet Sci 7: 376.
7. Hashino E, Kuboniwa M, Alghamdi SA, Yamaguchi M, Yamamoto R, Cho H, Amano A (2013) Erythritol alters microstructure and metabolomic profiles of biofilm composed of Streptococcus gordonii and Porphyromonas gingivalis. Mol Oral Microbiol 28: 435-451.
8. Ikeno H, Apel M, Zouboulis C, Luger TA, Böhm M (2015) L-ascorbyl-2-phosphate attenuates NF-κB signaling in SZ95 sebocytes without affecting IL-6 and IL-8 secretion. Arch Dermatol Res 307: 595-605.
9. Iwasaki T, Nagata M, Ohmuro T, Ando J (2008) Validation of a novel guideline for clinical trial of antimicrobials in canine bacterial py-oderma. Jpn J Vet Dermatol 14: 71-75.
10. Japanese Ministry of Health, Labour and Welfare Good Clinical Practice. Ministry of Health, Labour and Welfare Ministerial Ordinance, No. 28 dated March 27, 1997, and No. 24 dated February 29, 2008. Tokyo, Japan.(https://www.pmda.go.jp/files/000152996.pdf)
11. Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS (2019) Fitzpatrick’s Dermatology. 9th ed., McGraw-Hill Education, Chapter 150.
12. Kawakami T, Shibata S, Murayama N, Nagata M, Nishifuji K, Iwasaki T, Fukata T (2010) Antimicrobial susceptibility and methicillin resistance in Staphylococcus pseudintermedius and Staphylococcus schleiferi subsp. coagulans isolated from dogs with pyoderma in Ja-pan. J Vet Med Sci 72: 1615-1619.
13. Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, Nomicos E, Polley EC, Komarrow HD, NISC CSP, Murray PR, Turner ML, Segre JA (2012) Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermati-tis. Genome Res 22: 850-859.
14. Miyasawa-Hori H, Aizawa S, Takahashi N (2006) Difference in the xylitol sensitivity of acid production among Streptococcus mutans strains and the biochemical mechanism. Oral Microbiol Immunol 21: 201-205.
15. Murray C, Ahrens K, Devalaraja M, Dymond M, Fagura M, Hargreaves A, Holt A, Peers I, Price S, Reens J, Riley R, Marsella R (2016) Use of a canine model of atopic dermatitis to investigate the efficacy of a CCR4 antagonist in allergen-induced skin inflammation in a randomized study. J Invest Dermatol 136: 665-671.
16. Nakakuki T (2003) Development of functional oligosaccharides in Japan. Trends Glycosci Glycotechnol 82: 57-64.
17. Nayama S, Takehana M, Kanke M, Itoh S, Ogata E, Kobayashi S (1999) Protective effects of sodium-L-ascorbyl-2 phosphate on the de-velopment of UVB-induced damage in cultured mouse skin. Biol Pharm Bull 22: 1301-1305.
18. Norström M, Sunde M, Tharaldsen H, Mørk T, Bergsjø B, Kruse H (2009) Antimicrobial resistance in Staphylococcus pseudintermedi-us in the Norwegian dog population. Microb Drug Resist 15: 55-59.
19. Rafeek R, Carrington CVF, Gomez A, Harkins D, Torralba M, Kuelbs C, Addae J, Moustafa A, Nelson KE (2019) Xylitol and sorbitol effects on the microbiome of saliva and plaque. J Oral Microbiol 11: 1536181. 20. Santoro D (2023) Topical therapy for canine pyoderma: what is new? J Am Vet Med Assoc. 261: S140-S148.
21. Scott DW (2007) Color atlas of farm animal dermatology. 2nd ed., Wiley-Blackwell.
22. Shannon CE (1948) A mathematical theory of communication. Bell Syst Tech J 27: 379-423.
23. Söderling E, ElSalhy M, Honkala E, Fontana M, Flannagan S, Eckert G, Kokaras A, Paster B, Tolvalen M, Honkala S (2015) Effects of short-term xylitol gum chewing on the oral microbiome. Clin Oral Investig 19: 237-244.
24. Söderling E, Pienihäkkinen K (2020) Effects of xylitol and erythritol consumption on mutans streptococci and the oral microbiota: a sys-tematic review. Acta Odontol Scand 78: 599-608.
25. Woolery-Lloyd H, Baumann L, Ikeno H (2010) Sodium L-ascorbyl-2-phosphate 5% lotion for the treatment of acne vulgaris: A ran-domized, double-blind, controlled trial. J Cosmet Dermatol 9: 22-27.
Go to article

Authors and Affiliations

T. Tochio
1 2
K. Kawano
2 3
K. Iyori
4
R. Makida
1
Y. Kadota
1
T. Fujii
1
H. Ishikawa
5
T. Yasutake
5
A. Watanabe
2
K. Funasaka
2
Y. Hirooka
2
K. Nishifuji
6

  1. B Food Science Co., Ltd., 24-12, Kitahama-machi, Chita, Aichi 478-0046, Japan
  2. Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Aichi 470-1192, Japan
  3. Tokyo Animal Allergy Center, 4-23-15, Kurihara, Adachi-ku, Tokyo 123-0842, Japan
  4. Vet Derm Tokyo, Dermatological and Laboratory Service for Animals, 910 Shoubusawa, Fujisawa, Kanagawa 252-0823, Japan
  5. Healthcare Systems Co., Ltd., Nagoya Aichi, 466-0058, Japan
  6. Division of Animal Life Science, Institute of Agriculture, Graduate School, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509, Japan
Download PDF Download RIS Download Bibtex

Abstract

Erythritol helps both prevent and improve periodontal disease and is therefore widely used for dental care in humans. However, only a few studies have investigated the effects of erythritol on periodontal disease in animals. We hypothesized that erythritol could be used to prevent and improve periodontal disease also in canines and investigated the effects of erythritol on canine periodontal disease–related pathogenic bacteria using both in vitro and in vivo methods.
The effect of erythritol on the proliferation of Porphyromonas gulae, which is reportedly associated with canine periodontal disease, was investigated in vitro. In addition, a 4-week intervention trial using an external gel preparation containing 5% erythritol was performed in canines with mild periodontal disease; changes in the microbiota around periodontal lesions were investigated using next-generation sequencing and bioinformatics analysis.
The growth of P. gulae was significantly suppressed by erythritol in vitro. In the intervention study, the Shannon index, an indicator of the species distribution α-diversity, and the occupancy of several canine periodontal disease – related bacteria ( P. gulae, P. cangingivalis) were significantly decreased in periodontal lesions.
Based on the results of in vitro and in vivo studies, we conclude that, as in humans, erythritol has bacteriostatic effects against periodontal disease – related bacteria in canines.
Go to article

Bibliography

Allaker RP, Young KA, Langlois T, Rosayro RD, Hardie JM (1997) Dental plaque flora of the dog with reference to fastidious and anaerobic bacteria associated with bites. J Vet Dent 14: 127-130.
Bellows J, Berg ML, Dennis S, Harvey R, Lobprise HB, Snyder CJ, Stone AES, Van de Wetering AG (2019) AAHA Dental Care Guidelines for Dogs and Cats. J Am Anim Hosp Assoc 55: 49-69.
Chen Y, Liao K, Ai L, Guo P, Huang H, Wu Z, Liu M (2017) Bacteremia caused by Bergeyella zoohelcum in an infective endocarditis patient: case report and review of literature. BMC Infect Dis 17: 271.
Dean I, Jackson F, Greenough RJ (1996) Chronic (1-year) oral toxicity study of erythritol in dogs. Regul Toxicol Pharmacol 24: S254-S260.
de Cock P (2018) Erythritol functional roles in oral-systemic health. Adv Dent Res 29: 104-109.
de Cock P, Mäkinen K, Honkala E, Saag M, Kennepohl E, Eapen A (2016) Erythritol is more effective than xylitol and sorbitol in managing oral health endpoints. Int J Dent 2016: 9868421.
Dos Santos JD, Cunha E, Nunes T, Tavares L, Oliveira M (2019) Relation between periodontal disease and systemic diseases in dogs. Res Vet Sci 125: 136-140.
Eubanks DL (2010) Periodontal disease assessment. J Vet Dent 27: 58-60.
Gu Y, Fujitomo Y, Ohmagari N (2021) Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016-2020). Antibiotics 10: 1293.
Hashino E, Kuboniwa M, Alghamdi SA, Yamaguchi M, Yamamoto R, Cho H, Amano A (2013) Erythritol alters microstructure and metabolomic profiles of biofilm composed of Streptococcus gordonii and Porphyromonas gingivalis. Mol Oral Microbiol 28: 435-451.
Kortegaard HE, Eriksen T, Baelum V (2008) Periodontal disease in research beagle dogs-an epidemiological study. J Small Anim Pract 49: 610-616.
Kuzuya T, Kanazawa Y, Kosaka K (1969) Stimulation of insulin secretion by xylitol in dogs. Endocrinology 84: 200-207.
Lozupone CA, Hamady M, Kelley ST, Knight R (2007) Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities. Appl Environ Microbiol 73: 1576-1585.
Munro IC, Berndt WO, Borzelleca JF, Flamm G, Lynch BS, Kennepohl E, Bär E A, Modderman J (1998) Erythritol: an interpretive summary of biochemical, metabolic, toxicological and clinical data. Food Chem Toxicol 36: 1139-1174.
Muramatsu Y, Haraya N, Horie K, Uchida L, Kooriyama T, Suzuki A, Horiuchi M (2019) Bergeyella zoohelcum isolated from oral cavities of therapy dogs. Zoonoses Public Health 66: 936-942.
Murphy LA, Coleman AE (2012) Xylitol toxicosis in dogs. Vet Clin North Am Small Anim Pract 42: 307-312.
Nakakuki T (1998) Development of functional oligosaccharides in Japan. Trends Glycosci. Glycotechnol. 178: 19-28.
Noda K, Nakayama K, Modderman J (1996) Fate of erythritol after single oral administration to rats and dogs. Regul Toxicol Pharmacol 24: S206-S213.
Nomura R, Inaba H, Yasuda H, Shirai M, Kato Y, Murakami M, Iwashita N, Shirahata S, Yoshida S, Matayoshi S, Yasuda J, Arai N, Asai F, Matsumoto-Nakano M, Nakano K (2020) Inhibition of Porphyromonas gulae and periodontal disease in dogs by a combination of clindamycin and interferon alpha. Sci Rep 10: 3113.
Nomura R, Shirai M, Kato Y, Murakami M, Nakano K, Hirai N, Mizusawa T, Naka S, Yamasaki Y, Matsumoto-Nakano M, Ooshima T, Asai F (2012) Diversity of fimbrillin among Porphyromonas gulae clinical isolates from Japanese dogs. J Vet Med Sci 74: 885-891.
Sarkiala E, Harvey C (1993) Systemic antimicrobials in the treatment of periodontitis in dogs. Semin Vet Med Surg Small Anim 8: 197-203.
Senhorinho GN, Nakano V, Liu C, Song Y, Finegold SM, Avila-Campos MJ (2011) Detection of Porphyromonas gulae from subgingival biofilms of dogs with and without periodontitis. Anaerobe 17: 257-258.
Shannon CE (1949) A mathematical theory of communication. Bell Syst Tech J 27: 379-423.
Shoukry M, Ben AL, Abdel NM, Soliman A. (2007) Repair of experimental plaque-induced periodontal disease in dogs. J Vet Dent 24: 152-165.
Yumoto T, Kowada T, Sumiya F, Matsumoto T, Fujita K, Yamamura H, Sakai T (2004) Surgery and bacteria isolation in treating severe periodontal disease in old dogs. J Jpn Vet Med Assoc 57: 41-45.
Go to article

Authors and Affiliations

T. Tochio
1 2
R. Makida
1
T. Fujii
1
Y. Kadota
1
M. Takahashi
1
A. Watanabe
2
K. Funasaka
2
Y. Hirooka
2
A. Yasukawa
3
K. Kawano
2 4

  1. B Food Science Co., Ltd., 24-12, Kitahama-machi, Chita, Aichi 478-0046, Japan
  2. Department of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Aichi 470-1192, Japan
  3. Kamishakujii Veterinary Medical Hospital, 1-4-13, Sekimachi-Higashi, Nerima-ku, Tokyo 177-0052, Japan
  4. Tokyo Animal Allergy Center, 4-23-15, Kurihara, Adachi-ku, Tokyo 123-0842, Japan

This page uses 'cookies'. Learn more